The cost of prescribing in general practice

Area of Science:

• Health Economics
• Patient Experience
• Pharmacoeconomics

Background:

• Understanding the comprehensive costs associated with common health conditions is crucial for healthcare resource allocation.
• Previous research has often focused on direct medical costs, neglecting patient-reported non-monetary impacts.

Purpose of the Study:

• To determine the National Health Service (NHS) and patient costs for back pain, depression, and eczema.
• To evaluate the effectiveness and non-monetary burdens of treatments for these conditions.

Main Methods:

• A sample of 77 patients consulting for back pain, depression, or eczema was studied.
• Medication costs were calculated by tracing prescription forms.
• Patient costs included monetary expenses, medication side effects, and socio-emotional impacts measured by the Nottingham Health Profile.

Main Results:

• Eczema consultations were most likely to result in prescription medication.
• Patients with depression incurred the highest mean medication costs.
• 61% of prescribed items reportedly improved patient conditions, most frequently for eczema and least for back pain.
• Non-monetary costs, such as social life disruption, were highest for depression.

Conclusions:

• Treatment costs and patient burdens vary significantly across different common conditions like back pain, depression, and eczema.
• A holistic approach considering both direct financial costs and indirect patient impacts is essential for effective healthcare management.
• Further research into optimizing treatment strategies to minimize both economic and socio-emotional costs is warranted.